ConductScience.org, home

Comparison · NCT00970489-885a45ef

Olive Oil Capsule vs Omega-3 Fatty Acid Capsules: Any First Post-op Atrial Fibrillation or Flutter (AF)

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Olive Oil Capsule vs Omega-3 Fatty Acid Capsules: Any First Post-op Atrial Fibrillation or Flutter (AF). Trial comparisons, record NCT00970489-885a45ef. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00970489-885a45ef

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.3070.2760.341wilson
Risk in group 20.2990.2680.333wilson
Risk difference, group 1 minus group 20.00792-0.03830.0541newcombe hybrid score
Risk ratio, group 1 over group 21.030.8811.2log
Odds ratio, group 1 over group 21.040.8341.29log
Number needed to treat, for one more participant with the outcome on Olive Oil Capsule than on Omega-3 Fatty Acid Capsules126from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Olive Oil CapsulePlacebo : Olive Oil capsules233758OG000
Group 2Omega-3 Fatty Acid Capsules
Omega -3 fatty acids : 10g dose of oral omega-3 fatty acid capsules over 3-5 days before surgery (or 8 g over 2 days before surgery), including the morning of surgery, followed by 2g/d after surgery for 10 days, or until discharge, whichever occurs first.
227758OG001

Outcome

Type
PRIMARY
Title
Any First Post-op Atrial Fibrillation or Flutter (AF)
Description
Primary: Occurrence of post-CS AF (atrial fibrillation or flutter) of at least 30 seconds duration and confirmed by rhythm strip or 12-lead ECG. This will include definite AF and probable AF (SVT likely to be AF depending on rate and other characteristics).
Time frame
up to 10 days post-surgery or discharge, whichever sooner
Population

Source ClinicalTrials.gov

Trial

Title
Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation
NCT number
NCT00970489
Phases
PHASE3
Conditions
Atrial Fibrillation
Interventions
Omega -3 fatty acids, Placebo
Lead sponsor
Brigham and Women's Hospital
Results first posted
2017-04-10

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00970489-885a45ef